LRP6 and colorectal cancer: Importantly, although HCT116 are colorectal cancer cells that harbor an activating mutation in β-catenin, they respond to Wnt ligands by LRP6 activation and increased proliferation [31], making them a suitable model for studying cyclin Y biology.